|
Market Closed -
OTC Markets
17:31:28 04/06/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.0290 USD | +6.62% |
|
+241.18% | -52.77% |
| 08-13 | CV Sciences, Inc., Q2 2026 Earnings Call, Aug 13, 2026 | |
| 08-13 | CV Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 1.76M 1.58M 1.44M 1.32M 2.48M 166M 2.56M 17.4M 6.94M 88.35M 6.61M 6.47M 279M | P/E 2024 |
-2.48x | P/E 2025 | -11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 3.48M 3.12M 2.85M 2.6M 4.91M 327M 5.06M 34.38M 13.71M 175M 13.06M 12.78M 551M | EV / Sales 2024 |
0.42x | EV / Sales 2025 | 0.95x |
| Free-Float |
78.62% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: CV Sciences, Inc.
| 1 day | +6.62% | ||
| 1 week | +241.18% | ||
| Current month | +241.18% | ||
| 1 month | +114.02% | ||
| 3 months | +38.10% | ||
| 6 months | +1.40% | ||
| Current year | -52.77% |
| 1 week | 0.01 |  | 0.03 |
| 1 month | 0.01 | | 0.03 |
| Current year | 0.01 | | 0.1 |
| 1 year | 0.01 | | 0.1 |
| 3 years | 0.01 | | 0.1 |
| 5 years | 0.01 | | 0.26 |
| 10 years | 0.01 | | 9.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 68 | 30/05/2018 |
Joerg Grasser
DFI | Director of Finance/CFO | 51 | 14/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
BRD | Director/Board Member | 68 | 30/05/2018 |
Jamie Corroon
BRD | Director/Board Member | 56 | 20/07/2022 |
William McCorkle
BRD | Director/Board Member | 58 | 20/10/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/02/25 | Free | Chief Executive Officer | 3,000,000 | 1.6281% | ||
| 18/02/25 | Free | Director | 500,000 | 0.2714% | ||
| 18/02/25 | Free | Director | 500,000 | 0.2714% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.62% | +241.18% | -7.94% | -14.71% | 1.76M | |
| -0.79% | -4.48% | +44.44% | +127.49% | 1,206B | |
| +1.43% | +1.11% | +47.73% | +82.08% | 665B | |
| +1.07% | -1.21% | +32.99% | +106.31% | 515B | |
| -0.36% | -3.25% | +47.17% | +64.58% | 381B | |
| -0.14% | -1.87% | +71.05% | +40.63% | 362B | |
| -0.78% | -0.52% | +30.57% | +57.98% | 307B | |
| -0.80% | -0.21% | +8.54% | +35.56% | 289B | |
| +0.03% | -1.20% | +45.89% | +68.76% | 249B | |
| -0.41% | -2.22% | +35.24% | +105.68% | 207B | |
| Average | +0.59% | -1.38% | +35.57% | +67.44% | 417.97B | |
| Weighted average by Cap. | -0.04% | -1.96% | +42.24% | +88.38% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 15.7M 14.09M 12.87M 11.75M 22.14M 1.48B 22.84M 155M 61.87M 788M 58.95M 57.68M 2.49B | 13.79M 12.37M 11.3M 10.32M 19.44M 1.3B 20.05M 136M 54.32M 692M 51.76M 50.65M 2.18B |
| Net income | -2.39M -2.15M -1.96M -1.79M -3.37M -225M -3.48M -23.65M -9.43M -120M -8.99M -8.79M -379M | -958K -859K -785K -717K -1.35M -90.05M -1.39M -9.47M -3.77M -48.05M -3.6M -3.52M -152M |
| Net Debt | 325K 291K 266K 243K 458K 30.55M 473K 3.21M 1.28M 16.3M 1.22M 1.19M 51.46M | 1.72M 1.54M 1.41M 1.29M 2.42M 161M 2.5M 16.97M 6.77M 86.17M 6.45M 6.31M 272M |
Employees
43
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/11/26 | US$0.007800 | -13.33% | 2,591,353 |
| 05/11/26 | US$0.009000 | -10.00% | 1,209,524 |
| 04/11/26 | US$0.0100 | +17.65% | 1,971,536 |
| 03/11/26 | US$0.008500 | +6.25% | 1,764,493 |
| 02/11/26 | US$0.008000 | -5.88% | 437,926 |
- Stock Market
- Stocks
- CVSI Stock
Select your edition
All financial news and data tailored to specific country editions
